Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine in Breast Reconstruction
NCT02659501Terminated
- Sponsor
- Loma Linda University
- Start
- Jul 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine extended release liposome injection in postoperative pain (2 arms), sponsored by Loma Linda University. Primary endpoints: Average Postoperative Pain Levels at 24 hours, Antiemetic Consumption at 24 hours and 3 more. Started Jul 2015; status: terminated.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02659501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659501.